Skip to main content

LIVE

PDEX

Pro-Dex, Inc.

PDEX

NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $234.4M

$73.41

+18.88%

P/E

22.18

Mkt Cap

$234.4M

52-Wk Range

$23.47–$77.00

52-Week Range

$23.47 - $77.00

P/E

22.18

Fwd P/E

26.41

Beta

0.06

Div Yield

0.00%

Avg Vol

70.5K

Shares Out

3.2M

Mkt Cap

$234.4M

Price action

Price chart

Up 106.4% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • 45+ years of specialized expertise in powered surgical instrument design and manufacturing
  • Strong relationships with leading medical device OEMs and established market presence
  • Proprietary autoclavable technology and multi-function surgical driver platforms
  • Integrated consulting services providing regulatory and quality expertise to customers

Bear Case

2 risks

  • Low volatility (beta 0.1).
  • Premium valuation to Medical Devices peers

Growth

Stable outlook

Rising global demand for minimally invasive surgical procedures and advanced surgical instruments

Value

Premium valuation to Medical Devices peers

Momentum

Strong

+12.9% over 3m

Quality

Stable

Excellent business quality

Dividend

None

No dividend

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 31, 2026

Q3 26 RECAP

SEP 3, 2026

Reported EPS of $0.87 vs $0.67 consensus (+29.9% surprise). Revenue of $20.4M vs $19.2M expected (+6.3%). Beat on both top and bottom lines.

EPS beat +29.9%
Rev beat +6.3%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+29.9%

Revenue trend · last 8Q

+33%

+22%

+16%

+24%

+11%

+17%

Q4 24

Q1 24

Q2 24

Q3 25

Q4 25

Q1 25

Q2 25

Q4 26

$15.0M

$14.9M

$16.8M

$17.4M

$17.5M

$18.5M

$18.7M

$20.4M

Margins · last 8Q

Gross

34.8%

Operating

17.3%

Profit

14.0%

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

Latest: Ascendiant Capital · May 12, 2026

vs Industry

How PDEX stacks vs Medical - Instruments & Supplies

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.